Cargando…
Polycomb group expression signatures in the malignant progression of gliomas
Polycomb group (PcG) proteins form at least two key complexes, namely polycomb repressive complex 1 and polycomb repressive complex 2. These complexes are involved in the progression of various cancers. Systematic research has not been conducted on the aberrant expression of PcG members in gliomas....
Autores principales: | Hu, Qi, Wu, Weining, Zeng, Ailiang, Yu, Tianfu, Shen, Feng, Nie, Er, Wang, Yingyi, Liu, Ning, Zhang, Junxia, You, Yongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403712/ https://www.ncbi.nlm.nih.gov/pubmed/28454437 http://dx.doi.org/10.3892/ol.2017.5753 |
Ejemplares similares
-
MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53
por: Zhou, Xu, et al.
Publicado: (2017) -
EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma
por: Zhi, Tongle, et al.
Publicado: (2017) -
Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
por: Nie, Er, et al.
Publicado: (2018) -
CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1
por: Yu, Tianfu, et al.
Publicado: (2017) -
Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastoma
por: Wu, Weining, et al.
Publicado: (2017)